| Associations of SGLT-2i with Cardiorenal Outcomes Among Diabetics with Prostate Cancer on Hormone Therapy E Koutroumpakis, R Patel, S Khadke, A Bedrosian, A Kumar, Y Kong, ... | | 2024 |
| Use of Positron Emission Tomography for The Diagnosis of Immune Checkpoint Inhibitor Myocarditis A Ali, Y Lu, S Khalaf, C Iliescu, E Koutroumpakis, SW Yusuf, BA Siddiqui, ... Journal of Nuclear Cardiology, 2024 | | 2024 |
| Body composition as a determinant of the therapeutic index with androgen signaling inhibition AW Hahn, RS Tidwell, PG Pilie, Y Yu, J Liu, DS Surasi, M Titus, J Zhang, ... Prostate Cancer and Prostatic Diseases, 1-7, 2024 | | 2024 |
| Pilot study on the utilization of a non-invasive µCor device for monitoring fluid status and cardiac biomarkers during treatment for patients with hematologic malignancies. A Ali, E Pierce, J Song, E Koutroumpakis, N Palaskas, A Deswal, ... Journal of Clinical Oncology 42 (16_suppl), e18507-e18507, 2024 | | 2024 |
| Limitations of apical sparing pattern in cardiac amyloidosis: a multicentre echocardiographic study J Cotella, M Randazzo, MS Maurer, S Helmke, M Scherrer-Crosbie, ... European Heart Journal-Cardiovascular Imaging 25 (6), 754-761, 2024 | 5 | 2024 |
| Longitudinal changes in the carotid arteries of head and neck cancer patients following radiation therapy: Results from a prospective serial imaging biomarker characterization … E Koutroumpakis, ASR Mohamed, P Chaftari, DI Rosenthal, D Gujral, ... Radiotherapy and Oncology 195, 110220, 2024 | 1 | 2024 |
| The need for precision medicine in managing cardiovascular risk for men receiving ADT AW Hahn, E Koutroumpakis, V Narayan, A Aparicio Prostate Cancer and Prostatic Diseases, 1-2, 2024 | | 2024 |
| Cardiovascular toxicity of immune therapies for cancer NL Palaskas, HJ Ali, E Koutroumpakis, S Ganatra, A Deswal bmj 385, 2024 | 3 | 2024 |
| Elevated IL-6 and Tumor Necrosis Factor-α in Immune Checkpoint Inhibitor Myocarditis A Ali, R Caldwell, G Pina, N Beinart, G Jensen, SW Yusuf, ... Diseases 12 (5), 88, 2024 | 1 | 2024 |
| PO-01-066 A SINGLE CENTER ANALYSIS OF IMMUNE CHECKPOINT INHIBITOR-ASSOCIATED MYOCARDITIS AND THE ASSOCIATION OF ELECTROCARDIOGRAPHIC CHANGES AND ARRHYTHMIAS N King, A Ruiz-Jurado, N Beinart, HJ Ali, I Hamzeh, S Khalaf, ... Heart Rhythm 21 (5), S197-S198, 2024 | | 2024 |
| PO-01-067 IMMUNE CHECKPOINT INHIBITOR-ASSOCIATED MYOCARDITIS COMPLICATED BY CONDUCTION SYSTEM DISEASE NEEDING PACEMAKER IMPLANTATION: A SINGLE CENTER EXPERIENCE OF PACING OUTCOMES N King, A Ruiz-Jurado, N Beinart, HJ Ali, I Hamzeh, S Khalaf, ... Heart Rhythm 21 (5), S198, 2024 | | 2024 |
| CARDIOVASCULAR MORTALITY TRENDS IN PROSTATE CANCER PATIENTS: INSIGHTS FROM THE SEER 17 DATABASE (2010-2015) A Ali, A Ebied, E Koutroumpakis, D Monlezun, M Sakr, M Osama, M Lee, ... Journal of the American College of Cardiology 83 (13_Supplement), 2654-2654, 2024 | | 2024 |
| LIMITATIONS OF ECHOCARDIOGRAPHIC APICAL-SPARING STRAIN PATTERN IN CARDIAC AMYLOIDOSIS: A MULTICENTER STUDY M Randazzo, JI Cotella, MS Maurer, M Scherrer-Crosbie, M Soltani, ... Journal of the American College of Cardiology 83 (13_Supplement), 1367-1367, 2024 | | 2024 |
| ECHOCARDIOGRAPHIC ASSESSMENT OF THE LEFT AND RIGHT ATRIUM IN SYSTEMIC AL AMYLOIDOSIS WITH AND WITHOUT CARDIAC INVOLVEMENT S Singh, C Miller, J Song, A Ali, F Cervoni-Curet, C Iliescu, S Khalaf, ... Journal of the American College of Cardiology 83 (13_Supplement), 2564-2564, 2024 | | 2024 |
| THE BURDEN OF SUBCLINICAL CORONARY ARTERY DISEASE AS MEASURED BY CORONARY ARTERY CALCIFICATION AND ASSOCIATION WITH LEPTIN LEVELS IN PATIENTS WITH METASTATIC PROSTATE CANCER E Koutroumpakis, N Venkatesh, A Aparicio, J Song, A Deswal, ... Journal of the American College of Cardiology 83 (13_Supplement), 2347-2347, 2024 | | 2024 |
| Survival outcomes and toxicity of adjuvant immunotherapy after definitive concurrent chemotherapy with proton beam radiation therapy for patients with inoperable locally … KL Corrigan, T Xu, Y Sasaki, R Lin, AB Chen, JW Welsh, SH Lin, ... Radiotherapy and Oncology 193, 110121, 2024 | 1 | 2024 |
| In adults with overweight or obesity and CVD, but without diabetes, semaglutide reduced MACE at a mean 40 mo E Koutroumpakis, A Deswal Annals of internal medicine 177 (3), JC31, 2024 | | 2024 |
| Navigating P2Y12 inhibition in the labyrinth of cardio-oncology care: cangrelor bridging in patients with cancer A Ali, P Jewani, M Bourdillon, E Koutroumpakis, S Khalaf, K Charitakis, ... Frontiers in Cardiovascular Medicine 11, 1337957, 2024 | | 2024 |
| Detection of Alteration in Carotid Artery Volumetry Using Standard-of-care Computed Tomography Surveillance Scans Following Unilateral Radiation Therapy for Early-stage … E Koutroumpakis, MA Naser, ASR Mohamed, SA Eraj, A Jarre, JC Shiao, ... medRxiv, 2024.02. 03.24302288, 2024 | | 2024 |
| Association of inherited steroidogenic genotype with body composition changes after androgen signaling inhibition (ASI) in men with biochemical recurrent (BCR), hormone … N Venkatesh, R Tidwell, Y Yu, A Aparicio, AJ Zurita, SK Subudhi, ... Journal of Clinical Oncology 42 (4_suppl), 108-108, 2024 | | 2024 |
